Area of research
Surgery · Transplantation
Research interest
Research interests include Transplantation: Methods and Outcomes, Renal Transplantation Outcomes and Treatments, Mechanical Circulatory Support Devices, and Organ Transplantation Techniques and Outcomes.
Utility of Right Ventricular Mass Ratios in Recipients With Pulmonary Hypertension: A United Network for Organ-Sharing Database Analysis.
Long-term post-transplantation outcomes in patients with hypertrophic cardiomyopathy: Single-center 35-year experience.
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
Dietary sugar intake and risk of Alzheimer's disease in older women.
Proceedings from the metrics forum in heart transplantation for performance monitoring.
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry
Frailty in heart transplantation: Report from the heart workgroup of a consensus conference on frailty.
Proceedings from the metrics forum in heart transplantation for performance monitoring
CAVEAT mTOR: You've heard about the benefits of using mTOR inhibitors, here are some of the risks.
Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside
New French heart allocation system: Comparison with Eurotransplant and US allocation systems.
Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside.
The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019.
Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation
Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications.
mTOR inhibitors vs calcineurin inhibitors: A Catch-22-preventing nephrotoxicity or acute allograft rejection after heart transplantation.
Temporal Trends of De Novo Malignancy Development After Heart Transplantation
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload
Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States
mTOR-Inhibitor-Attributed Events: Review of 2-Year Safety Data in Heart Transplant Recipients Receiving Everolimus Vs MMF in the Randomised Multi-Centre 2310 Study
24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study